|Titre :||Controlling new drugs under marketing regulations [For debate] (2012)|
|Auteurs :||B. HUGHES, Auteur ; A. R. WINSTOCK, Auteur ; K. KRAJEWSKI, Auteur du commentaire ; J. SHERIDAN, Auteur du commentaire ; B. ATMORE, Auteur du commentaire ; B. RUSSELL, Auteur du commentaire ; P. REUTER, Auteur du commentaire ; T. P. FREEMAN, Auteur du commentaire ; H. V. CURRAN, Auteur du commentaire|
|Type de document :||Article : Périodique|
|Dans :||Addiction (Vol.107, n°11, November 2012)|
|Article en page(s) :||1894-1899|
|Note générale :||
• Against excess. Krajewski K., p. 1900-1901.
• New Zealand to establish fit for purpose regulation for new psychoactive substances. Sheridan J., Atmore B., Russell B., p. 1901-1902.
• The dangerous charms of the unknown. Reuter P., p. 1902-1903.
• Supply always comes on the heels of demand: what effects do control strategies have on drug users themselves? Freeman T.P., Curran H.V., p. 1903-1905.
Letter to the editor: No quick fix for legal highs. Parsons J., p. 2053-2054.
|Discipline :||MAR (Marché de la drogue / Drug market)|
Thésaurus TOXIBASEPHENOMENE EMERGENT ; DROGUES DE SYNTHESE ; CONTROLE DES STUPEFIANTS ; MARKETING ; LEGISLATION ; POLITIQUE ; VENTE ; MARCHE DE LA DROGUE ; REGLEMENTATION
Thésaurus GéographiqueEUROPE ; UNION EUROPEENNE ; NOUVELLE ZELANDE
Aims: The rapid emergence of myriad substances openly marketed as ‘legal highs’ is straining traditional drug control systems which require time and basic scientific data on harms to react, presenting governments with the dilemma of no response or a disproportionate response. Some countries have side-stepped this using novel policy and legislative approaches. Should other countries consider them?
Methods: We review the different laws invoked to stop the open sale of new psychoactive substances, focusing on the European Union (EU).
Results: Some countries have designed new catch-all control systems, or faster systems to classify substances as drugs. Others have enforced consumer safety or medicines legislation to stop the open sale of these products. The latter originate from harmonization of the internal market of the EU. Rigorous, objective evaluation is required, but first results suggest that these have been effective, while avoiding criminalization of users.
Conclusions: Every EU country should have existing laws for protecting public health that can be applied swiftly yet proportionately to new drugs appearing on the open market with minimum political involvement. It seems the key is the speed, not the weight, of response. Given support for their enforcement mechanisms, these systems might be as effective and more efficient than the old ones.
|Domaine :||Autres substances / Other substances ; Drogues illicites / Illicit drugs|
|Refs biblio. :||36|
|Affiliation :||European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal|